Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01304407 · ClinicalTrials.gov registry record · NA
Calcium Absorption in Patients With Rothmund-Thomson Syndrome
A NA study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT01304407 is a NA study that has completed, run by Baylor College of Medicine. The registered enrollment target is 29 participants.
The verdict
NCT01304407, a NA study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
Osteosarcoma is the most common malignant bone tumor in children and adolescents. Because cure rates for osteosarcoma have remained stagnant for the past several decades despite numerous trials of chemotherapy agents, novel therapies based on the understanding of the molecular pathogenesis of osteosarcoma are needed. Rothmund-Thomson Syndrome (RTS) is a genetic disorder affecting many parts of the body and resulting in major skeletal abnormalities. This disease also has the propensity to increase the risk of developing cancer, particularly osteosarcoma. Two-thirds of RTS patients have a high risk of developing osteosarcoma. Therefore, it is important to understand the impact of RTS on the skeletal phenotype (as measured by bone density) in order to develop effective therapies to battle osteosarcoma.
Interventions
- OTHER Calcium stable isotope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2011-03 |
| Est. Completion | 2017-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01304407
The ClinicalTrials.gov registry entry for NCT01304407 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calcium stable isotope is the first listed.
NCT01304407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01304407 about?
NCT01304407 is a clinical study titled "Calcium Absorption in Patients With Rothmund-Thomson Syndrome". Osteosarcoma is the most common malignant bone tumor in children and adolescents. Because cure rates for osteosarcoma have remained stagnant for the past several decades despite numerous trials of chemotherapy agents, novel therapies based on the understanding of the molecular pathogenesis of osteos...
What is the current status of trial NCT01304407?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2011-03. Estimated completion is 2017-02.
What interventions are being tested in trial NCT01304407?
The interventions under investigation include: Calcium stable isotope (OTHER).
Who is sponsoring clinical trial NCT01304407?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.